|
|
|
| |
 |
|
|
|
推薦指數：
|
|
- 內容介紹
|
Hypertension: A Companion to Braunwald's Heart Disease, 2nd Edition
Expert Consult - Online and Print
By Henry R. Black, MD
Expert Consult
Reference
608 Pages
Trim Size: 8 3/4 X 11 1/16 in
Imprint: Saunders
ISBN: 978-1-4377-2766-1
Copyright: 2012
Effectively manage the chronic problems of your hypertensive patients with the practical clinical tools inside Hypertension, 2nd Edition: A Companion to Braunwald's Heart Disease. This respected cardiology reference covers everything you need to know - from epidemiology and pathophysiology through diagnosis, risk stratification, treatment, outcome studies, concomitant diseases, special populations and special situations, and future treatments
New to This Edition
Use new combination drug therapies and other forms of treatment to their greatest advantage in the management of chronic complications of hypertension.
Successfully employ behavior management as a vital part of the treatment plan for hypertensives and pre-hypertensives.
Access the complete contents online and download images at www.expertconsult.com.
.Key Features
Confidently meet the needs of special populations with chronic hypertensive disease, as well as hypertension and concomitant disease.
Learn new methods of aggressive patient management and disease prevention to help ensure minimal risk of further cardiovascular problems.
Benefit from the authors' Clinical Pearls to reduce complications of hypertension.
.
Contents:
Section 1: Epidemiology & Pathophysiology
1. Epidemiology
2. Genetics of Hypertension
3. Pathogenesis of Hypertension
Section 2: Diagnosis
4. Definition of Hypertension
5. Measurement of Blood
6. Home BP Measurements
7. ABPM
8. Secondary Hypertension: Renovascular Hypertension
9. Secondary Hypertension: Mineralocorticoid Excess States
10. Secondary Hypertension: Pheochromocytoma
11. Secondary Hypertension: Sleep Apnea
12. Rare Unusual Diagnoses
Section 3: Risk Stratification
13. Natural History of (Untreated) Hypertension
14. The Special Problem of (Isolated) Systolic Hypertension
15. Assessment of Target Organ Damage
16. Prediction of Global Cardiovascular Risk
Section 4: Treatment
17. Lifestyle Modifications
18. Diuretics
19. Beta-blockers
20. ACE-inhibitors and Angiotensin II Receptor Blockers
21. Calcium Antagonists
22. Alpha-Blockers
23. Other (Newer) Drugs, including centrally-acting drugs, aldosterone antagonists, vasopeptidase inhibitors, and endothelin antagonists
Section 5: Outcome Studies
24. Design of Outcomes Studies
25. Meta-analyses
Section 6: Hypertension and Concomitant Diseases
26. Ischemic Heart Disease
27. Heart Failure
28. Kidney Disease
29. Transplant Hypertension
30. Obesity
31. Peripheral Vascular Disease
32. Cerebrovascular Disease
33. Diabetes
34. Dyslipidemia
Section 7: Special Populations & Special Situations
35. Pregnancy-Related Hypertension
36. Children and Adolescents
37. Elderly
38. Blacks
39. Hispanics
40. East Asians
41. South Asians
42. Refractory Hypertension
43. Peri-operative Hypertension
44. Emergencies and Urgencies
Section 8: Hypertension Treatment in the Future
45. Hypertension Disease Management Service
46. Hypertension Genomics
47. Approval Process for Antihypertensive DrugsUS and International
Section 9: Guidelines
48. US and Canadian Guidelines
49. European Guidelines
|
|
|
其他相關書藉
[ 
[ 